Antares Pharma Inc

:ATRS  
5.60
0.00 (+0.09%)
Products

Antares Pharma Announces FDA Approval Of Tlando, An Oral Treatment For Testosterone Replacement Therapy

Published: 03/29/2022 11:18 GMT
Antares Pharma Inc (ATRS) - Antares Pharma Announces FDA Approval of Tlando™, an Oral Treatment for Testosterone Replacement Therapy.
Antares Pharma Inc - Look Forward to Launching Tlando Commercially in Q2 of This Year.